Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05009225 · ClinicalTrials.gov registry record
Clinical Decision Support for Atrial Fibrillation and Flutter
A clinical trial of Atrial Fibrillation and Flutter, sponsored by Kaiser Permanente.
- Active
- Registry status
- 4,000
- Enrollment target
- 16
- Study locations
NCT05009225: Active study of Atrial Fibrillation and Flutter, sponsored by Kaiser Permanente.
NCT05009225 is a study of Atrial Fibrillation and Flutter that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 4,000 participants. The trial reports 16 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05009225, a study of Atrial Fibrillation and Flutter, is active but no longer recruiting, sponsored by Kaiser Permanente.
- ACTIVE NOT RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 16
- Study locations
Study Summary
Atrial fibrillation (AF) is a major public health problem: it impairs quality of life and independently heightens the risks of ischemic stroke, heart failure and all-cause mortality. AF is a common reason for presenting to emergency departments (ED) in Kaiser Permanente Northern California (KPNC) and is associated with frequent hospitalization. Additionally, inter-facility hospitalization rates for AF vary across KPNC. Improvements in modifiable components of ED AF care could potentially reduce low-yield hospitalizations and the associated costs, patient inconveniences, and complications that can ensue. Real-time clinical decision support systems (CDSS) can transform entrenched physician practices and improve patient outcomes. The investigators will conduct a stepped-wedge cluster randomized trial of a CDSS intervention across 13 KPNC EDs for the comprehensive management of acute AF with the following three aims: 1) To evaluate the impact of the CDSS intervention on index hospitalization rates; 2) To evaluate the impact of the CDSS intervention on ED AF rate and rhythm control process-of-care metrics; and 3) To evaluate the impact of the CDSS intervention on AF stroke prevention actions for eligible participants at the time of ED discharge. The investigators hypothesize that the CDSS intervention will safely reduce index hospitalization rates, improve rate and rhythm control process-of-care metrics, and increase stroke prevention actions for eligible participants at ED discharge and within 30 days.
Conditions Studied
Interventions
- OTHER Comprehensive ED AF management tool
Study Locations (16)
California
- Kaiser Permanente Antioch Emergency Department - Antioch
- Kaiser Permanente Fremont Emergency Department - Fremont
- Kaiser Permanente Manteca Medical Center - Manteca
- Kaiser Permanente Modesto Medical Center - Modesto
- Kaiser Permanente Oakland Emergency Department - Oakland
- Kaiser Permanente Richmond Emergency Department - Richmond
- Kaiser Permanente Roseville Emergency Department - Roseville
- Kaiser Permanente South Sacramento Emergency Department - Sacramento
- Kaiser Permanente Sacramento Emergency Department - Sacramento
- Kaiser Permanente San Francisco Emergency Department - San Francisco
- Kaiser Permanente San Jose Emergency Department - San Jose
- Kaiser Permanente San Leandro Emergency Department - San Leandro
- Kaiser Permanente San Rafael Emergency Department - San Rafael
- Kaiser Permanente Santa Clara Emergency Department - Santa Clara
- Kaiser Permanente South San Francisco Emergency Department - South San Francisco
- Kaiser Permanente Walnut Creek Medical Center - Walnut Creek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2024-06-30 |
What the registry record for NCT05009225 still lists
NCT05009225 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Atrial Fibrillation and Flutter appearing as the primary indexed condition, and to 1 intervention - of which Comprehensive ED AF management tool is the first listed.
NCT05009225 lists 16 locations in 1 state (California).
Frequently Asked Questions
What is clinical trial NCT05009225 about?
NCT05009225 is a clinical study titled "Clinical Decision Support for Atrial Fibrillation and Flutter". Atrial fibrillation (AF) is a major public health problem: it impairs quality of life and independently heightens the risks of ischemic stroke, heart failure and all-cause mortality. AF is a common reason for presenting to emergency departments (ED) in Kaiser Permanente Northern California (KPNC) an...
What is the current status of trial NCT05009225?
This trial is currently active not recruiting. The enrollment target is 4,000 participants. The study started on 2021-10-01. Estimated completion is 2024-06-30.
What conditions does trial NCT05009225 study?
This clinical trial studies the following conditions: Atrial Fibrillation and Flutter.
What interventions are being tested in trial NCT05009225?
The interventions under investigation include: Comprehensive ED AF management tool (OTHER).
Who is sponsoring clinical trial NCT05009225?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05009225 being conducted?
This trial has 16 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI